Kashmir Indepth
Kashmir

ISM distributes immunity booster among 17315 beneficiaries of Shopian

109 camps held across the district

SHOPIAN, AUGUST 25: In view of the COVID-19 pandemic, Indian System of Medicine (AYUSH) distributed immunity booster medicines among 17315 beneficiaries of block Keller, Shopian and Zainapora of district Shopian with effect from April 04, 2020 to August 25, 2020.

The ISM authorities highlighted the importance of strong immunity created by these immunity booster drugs in fighting against COVID-19 besides, various other important health aspects related to the deadly disease.

While distributing the medicines during these 109 camps held across the district, they said the people of these areas were advised to strictly follow the advisories issued by the government in letter and spirit besides they were also asked to stay indoors and not to venture out unnecessarily.

The beneficiaries of the concerned areas were also stressed to inform people from other areas to come forward for testing rather than pressing the panic button.

The people were advised to use face masks while going outside of their homes if and when necessary and also use hand sanitizers or wash hands with soap frequently.

The locals were directed to cooperate with the district administration and they were also assured that the district administration is always on forefront to provide better health care facilities to the people of the district.

Related posts

Works allotted without tenders, Admn approval earlier; JKPCC never tendered projects: CS

Kashmir Indepth

LG sets ‘2021 deadline’ for achieving 100 PC piped water supply in Jammu and Kashmir

Kashmir Indepth

Principal Chief Conservator of Forests inaugurates Wildlife Week 2020

Kashmir Indepth

M Raju reviews functioning of H&P, Civil Aviation, Estates Department

Kashmir Indepth

Cooking cost of Mid-Day Meal scheme to reach students through DBT mode

Kashmir Indepth

9 butchers booked under FSS Act

Zainab Hamdani

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy